{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:41Z","timestamp":1740107741194,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30770859,81170285"],"award-info":[{"award-number":["30770859,81170285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences(CIFMS).","award":["2017-I2M-2-002"],"award-info":[{"award-number":["2017-I2M-2-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10067-019-04895-6","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T01:02:51Z","timestamp":1578013371000},"page":"1591-1599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between plasma fibroblast growth factor 23 and left ventricular mass index in patients with Takayasu arteritis"],"prefix":"10.1007","volume":"39","author":[{"given":"Nan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3315-7840","authenticated-orcid":false,"given":"Aimin","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naqiang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"4895_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","volume":"120","author":"GS Kerr","year":"1994","unstructured":"Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120:919\u2013929. https:\/\/doi.org\/10.7326\/0003-4819-120-11-199406010-00004","journal-title":"Ann Intern Med"},{"key":"4895_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jaut.2014.01.012","volume":"48-49","author":"AW de Souza","year":"2014","unstructured":"de Souza AW, de Carvalho JF (2014) Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun 48-49:79\u201383. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.012","journal-title":"J Autoimmun"},{"key":"4895_CR3","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3899\/jrheum.161514","volume":"44","author":"J Li","year":"2017","unstructured":"Li J, Li H, Sun F, Chen Z, Yang Y, Zhao J, Li M, Tian X, Zeng X (2017) Clinical characteristics of heart involvement in Chinese patients with Takayasu arteritis. J Rheumatol 44:1867\u20131874. https:\/\/doi.org\/10.3899\/jrheum.161514","journal-title":"J Rheumatol"},{"key":"4895_CR4","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3899\/jrheum.140664","volume":"41","author":"L Yang","year":"2014","unstructured":"Yang L, Zhang H, Jiang X, Zou Y, Qin F, Song L, Guan T, Wu H, Xu L, Liu Y, Zhou X, Bian J, Hui R, Zheng D (2014) Clinical manifestations and longterm outcome for patients with Takayasu arteritis in China. J Rheumatol 41:2439\u20132446. https:\/\/doi.org\/10.3899\/jrheum.140664","journal-title":"J Rheumatol"},{"key":"4895_CR5","doi-asserted-by":"publisher","first-page":"e4069","DOI":"10.1097\/MD.0000000000004069","volume":"95","author":"J Li","year":"2016","unstructured":"Li J, Zhu M, Li M, Zheng W, Zhao J, Tian X, Zeng X (2016) Cause of death in Chinese Takayasu arteritis patients. Medicine(Baltimore) 95:e4069. https:\/\/doi.org\/10.1097\/MD.0000000000004069","journal-title":"Medicine(Baltimore)"},{"key":"4895_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435. https:\/\/doi.org\/10.1359\/JBMR.0301264","journal-title":"J Bone Miner Res"},{"key":"4895_CR7","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1172\/JCI32409","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003\u20134008. https:\/\/doi.org\/10.1172\/JCI32409","journal-title":"J Clin Invest"},{"key":"4895_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1681\/ASN.2017070772","volume":"29","author":"T Isakova","year":"2018","unstructured":"Isakova T, Cai X, Lee J, Xie D, Wang X, Mehta R, Allen NB, Scialla JJ, Pencina MJ, Anderson AH, Talierco J, Chen J, Fischer MJ, Steigerwalt SP, Leonard MB, Hsu CY, de Boer IH, Kusek JW, Feldman HI, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators (2018) Longitudinal FGF23 trajectories and mortality in patients with CKD. J Am Soc Nephrol 29:579\u2013590. https:\/\/doi.org\/10.1681\/ASN.2017070772","journal-title":"J Am Soc Nephrol"},{"key":"4895_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jamacardio.2018.0139","volume":"3","author":"B Panwar","year":"2018","unstructured":"Panwar B, Judd SE, Wadley VG, Jenny NS, Howard VJ, Safford MM, Guti\u00e9rrez OM (2018) Association of fibroblast growth factor 23 with risk of incident coronary heart disease in community-living adults. JAMA Cardiol 3:318\u2013325. https:\/\/doi.org\/10.1001\/jamacardio.2018.0139","journal-title":"JAMA Cardiol"},{"key":"4895_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2017.03.042","volume":"261","author":"Z Qin","year":"2017","unstructured":"Qin Z, Liu X, Song M, Zhou Q, Yu J, Zhou B, Wu Y, He Y, Huang L (2017) Fibroblast growth factor 23 as a predictor of cardiovascular and all-cause mortality in prospective studies. Atherosclerosis 261:1\u201311. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.03.042","journal-title":"Atherosclerosis"},{"key":"4895_CR11","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"Singh S, Grabner A, Yanucil C, Schramm K, Czaya B, Krick S, Czaja MJ, Bartz R, Abraham R, Di Marco GS, Brand M, Wolf M, Faul C (2016) Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int 90:985\u2013996. https:\/\/doi.org\/10.1016\/j.kint.2016.05.019","journal-title":"Kidney Int"},{"key":"4895_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1248\/bpb.b14-00276","volume":"38","author":"Y Masuda","year":"2015","unstructured":"Masuda Y, Ohta H, Morita Y, Nakayama Y, Miyake A, Itoh N, Konishi M (2015) Expression of FGF23 in activated dendritic cells and macrophages in response to immunological stimuli in mice. Biol Pharm Bull 38:687\u2013693. https:\/\/doi.org\/10.1248\/bpb.b14-00276","journal-title":"Biol Pharm Bull"},{"key":"4895_CR13","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2215\/CJN.13281211","volume":"7","author":"J Munoz Mendoza","year":"2012","unstructured":"Munoz Mendoza J, Isakova T, Ricardo AC et al (2012) Fibroblast growth factor 23 and inflammation in CKD. Clin J Am Soc Nephrol 7:1155\u20131162. https:\/\/doi.org\/10.2215\/CJN.13281211","journal-title":"Clin J Am Soc Nephrol"},{"key":"4895_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bone.2016.10.001","volume":"100","author":"C Faul","year":"2017","unstructured":"Faul C (2017) Cardiac actions of fibroblast growth factor 23. Bone 100:69\u201379. https:\/\/doi.org\/10.1016\/j.bone.2016.10.001","journal-title":"Bone"},{"key":"4895_CR15","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Guti\u00e9rrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393\u20134408. https:\/\/doi.org\/10.1172\/JCI46122","journal-title":"J Clin Invest"},{"key":"4895_CR16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/art.1780330811","volume":"33","author":"WP Arend","year":"1990","unstructured":"Arend WP, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129\u20131134. https:\/\/doi.org\/10.1002\/art.1780330811","journal-title":"Arthritis Rheum"},{"key":"4895_CR17","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1016\/S0167-5273(96)02813-6","volume":"54","author":"A Hata","year":"1996","unstructured":"Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54:S155\u2013S163","journal-title":"Int J Cardiol"},{"key":"4895_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, Horton K, Ogunyankin KO, Palma RA, Velazquez EJ (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 32:1\u201364. https:\/\/doi.org\/10.1016\/j.echo.2018.06.004","journal-title":"J Am Soc Echocardiogr"},{"key":"4895_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-x","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450\u2013458. https:\/\/doi.org\/10.1016\/0002-9149(86)90771-x","journal-title":"Am J Cardiol"},{"key":"4895_CR20","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Scientific Document Group (2018) 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J 39:3021\u20133104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"4895_CR21","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/rheumatology\/kex300","volume":"56","author":"F Alibaz-Oner","year":"2017","unstructured":"Alibaz-Oner F, Koster MJ, Unal AU, Yildirim HG, \u00c7ikik\u00e7i C, Schmidt J, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Direskeneli H, Warrington KJ (2017) Assessment of the frequency of cardiovascular risk factors in patients with Takayasu\u2019s arteritis. Rheumatology(Oxford) 56:1939\u20131944. https:\/\/doi.org\/10.1093\/rheumatology\/kex300","journal-title":"Rheumatology(Oxford)"},{"key":"4895_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/clc.22914","volume":"41","author":"E Akintoye","year":"2018","unstructured":"Akintoye E, Mahmoud K, Shokr M, Sandio A, Mallikethi-Reddy S, Sheikh M, Adegbala O, Egbe A, Briasoulis A, Afonso L (2018) Racial\/ethnic differences in the prognostic utility of left ventricular mass index for incident cardiovascular disease. Clin Cardiol 41:502\u2013509. https:\/\/doi.org\/10.1002\/clc.22914","journal-title":"Clin Cardiol"},{"key":"4895_CR23","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Guti\u00e9rrez","year":"2009","unstructured":"Guti\u00e9rrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119:2545\u20132552. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.844506","journal-title":"Circulation"},{"key":"4895_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","volume":"207","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE (2009) Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 207:546\u2013551. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.05.013","journal-title":"Atherosclerosis"},{"key":"4895_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fendo.2018.00278","volume":"9","author":"M Leifheit-Nestler","year":"2018","unstructured":"Leifheit-Nestler M, Haffner D (2018) Paracrine effects of FGF23 on the heart. Front Endocrinol (Lausanne) 9:278. https:\/\/doi.org\/10.3389\/fendo.2018.00278","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4895_CR26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","volume":"31","author":"M Leifheit-Nestler","year":"2016","unstructured":"Leifheit-Nestler M, Gro\u00dfe Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, Klintschar M, Becker JU, Erbersdobler A, Aufricht C, Seeman T, Fischer DC, Faul C, Haffner D (2016) Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. Nephrol Dial Transplant 31:1088\u20131099. https:\/\/doi.org\/10.1093\/ndt\/gfv421","journal-title":"Nephrol Dial Transplant"},{"key":"4895_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, Martin A, Fornoni A, di Marco GS, Kentrup D, Reuter S, Mayer AB, Pavenst\u00e4dt H, Stypmann J, Kuhn C, Hille S, Frey N, Leifheit-Nestler M, Richter B, Haffner D, Abraham R, Bange J, Sperl B, Ullrich A, Brand M, Wolf M, Faul C (2015) Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab 22:1020\u20131032. https:\/\/doi.org\/10.1016\/j.cmet.2015.09.002","journal-title":"Cell Metab"},{"key":"4895_CR28","doi-asserted-by":"publisher","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","volume":"7","author":"B Dai","year":"2012","unstructured":"Dai B, David V, Martin A, Huang J, Li H, Jiao Y, Gu W, Quarles LD (2012) A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. PLoS One 7:e44161. https:\/\/doi.org\/10.1371\/journal.pone.0044161","journal-title":"PLoS One"},{"key":"4895_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","volume":"89","author":"V David","year":"2016","unstructured":"David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M (2016) Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 89:135\u2013146. https:\/\/doi.org\/10.1038\/ki.2015.290","journal-title":"Kidney Int"},{"key":"4895_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.118.11060","volume":"72","author":"E Akhabue","year":"2018","unstructured":"Akhabue E, Montag S, Reis JP, Pool LR, Mehta R, Yancy CW, Zhao L, Wolf M, Gutierrez OM, Carnethon MR, Isakova T (2018) FGF23 (fibroblast growth factor-23) and incident hypertension in young and middle-aged adults: the CARDIA study (coronary artery risk development in young adults). Hypertension 72:70\u201376. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11060","journal-title":"Hypertension"},{"key":"4895_CR31","first-page":"149","volume":"31","author":"L Masi","year":"2013","unstructured":"Masi L, Franceschelli F, Leoncini G, Gozzini A, Rigante D, La Torre F, Matucci-Cerinic M, Brandi ML, Falcini F (2013) Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease? Clin Exp Rheumatol 31:149\u2013153","journal-title":"Clin Exp Rheumatol"},{"key":"4895_CR32","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.3390\/jcm7120558","volume":"7","author":"PJ Kotyla","year":"2018","unstructured":"Kotyla PJ, Kruszec-Zytniewska A, Owczarek AJ, Olszanecka-Glinianowicz M, Chudek J (2018) Fibroblast growth factor 23 to alpha-Klotho index correlates with systemic sclerosis activity: a proposal for novel disease activity marker. J Clin Med 7:e558. https:\/\/doi.org\/10.3390\/jcm7120558","journal-title":"J Clin Med"},{"key":"4895_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/rheumatology\/key040","volume":"58","author":"E Tombetti","year":"2019","unstructured":"Tombetti E, Mason JC (2019) Takayasu arteritis: advanced understanding is leading to new horizons. Rheumatology (Oxford) 58:206\u2013219. https:\/\/doi.org\/10.1093\/rheumatology\/key040","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04895-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:27:25Z","timestamp":1609547245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04895-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4895"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04895-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"13 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}